Literature DB >> 16894308

Expression of survivin in gastric cancer and its relationship with tumor angiogenesis.

Gi-Hoon Lee1, Young-Eun Joo, Yang-Seok Koh, Ik-Joo Chung, Young-Kyu Park, Jae-Hyuk Lee, Hyun-Soo Kim, Sung-Kyu Choi, Jong-Sun Rew, Chang-Soo Park, Sei-Jong Kim.   

Abstract

BACKGROUND/AIMS: Survivin, a member of inhibitors of apoptosis, has been found in various human cancers. Its expression is associated with tumor progression and adverse outcome. Angiogenesis is an essential process for the primary tumor to grow and invade the adjacent normal structures. Angiogenic factors such as vascular endothelial growth factor induce survivin expression in endothelial cells. The current study was designed to investigate the possible role of survivin and vascular endothelial growth factor status for angiogenesis in human gastric cancer.
METHODS: In this study, we conducted an immunohistochemical investigation of survivin and vascular endothelial growth factor expression in 106 tissue samples obtained from gastric cancer patients undergoing surgical treatment. To assess tumor angiogenesis, microvessel density was counted by staining endothelial cells immunohistochemically using anti-CD34 monoclonal antibody.
RESULTS: The positive expression of survivin and vascular endothelial growth factor in gastric cancer tissues was demonstrated in 50.0 and 69.8% of cases, respectively. The expression of survivin did not associate with vascular endothelial growth factor expression. Expression of survivin was significantly associated with tumor size, depth of invasion, lymph node metastasis, tumor stage and poor survival (P=0.011, 0.004, 0.020, 0.002, 0.046, respectively). High microvessel density was significantly associated with lymph node metastasis and poor survival (P=0.006 and 0.017, respectively). The mean microvessel density value of survivin positive tumors was 87.4+/-34.4 and significantly higher than that of survivin negative tumors (P=0.016). The mean microvessel density value of vascular endothelial growth factor positive tumors was 98.7+/-37.0 and significantly higher than that of vascular endothelial growth factor negative tumors (P=0.001). A combined analysis of survivin and vascular endothelial growth factor status showed that the mean microvessel density value of both positive tumors was 103.7+/-33.1 and significantly higher than that of both negative tumors (P<0.001).
CONCLUSION: These results suggest that survivin may play an important role in carcinogenesis by stimulating tumor angiogenesis in human gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16894308     DOI: 10.1097/01.meg.0000230086.83792.56

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  13 in total

1.  Role of survivin as prognostic and clinicopathological marker in gastric cancer: a meta-analysis.

Authors:  Andreas Krieg; Billur Baseras; Monika Tomczak; Pablo Emilio Verde; Nikolas Hendrik Stoecklein; Wolfram Trudo Knoefel
Journal:  Mol Biol Rep       Date:  2013-08-15       Impact factor: 2.316

2.  Down-regulation of survivin suppresses uro-plasminogen activator through transcription factor JunB.

Authors:  Kyung Hee Lee; Eun Young Choi; Sung Ae Koh; Min Kyoung Kim; Kyeong Ok Kim; Si Hyung Lee; Byung Ik Jang; Se Won Kim; Sang Woon Kim; Sun Kyo Song; Joon Hyuk Choi; Jae-Ryong Kim
Journal:  Exp Mol Med       Date:  2011-09-30       Impact factor: 8.718

3.  Expression of serum survivin protein in diagnosis and prognosis of gallbladder cancer: a comparative study.

Authors:  Jaya Nigam; Abhijit Chandra; Hasan Raza Kazmi; Anshuman Singh; Vishal Gupta; Devendra Parmar; Manoj Kumar Srivastava
Journal:  Med Oncol       Date:  2014-08-17       Impact factor: 3.064

4.  TFF3 and survivin expressions associate with a lower survival rate in gastric cancer.

Authors:  Jia-Rong Meng; Hui-Zhong Tang; Kai-Zong Zhou; Wu-Hong Shen; He-Yi Guo
Journal:  Clin Exp Med       Date:  2012-09-21       Impact factor: 3.984

5.  Antitumor effect of mSurvivinThr34→Ala in murine colon carcinoma when administered intravenously.

Authors:  Hong-xia Li; Xin-yu Zhao; Lian Wang; Yong-sheng Wang; Bin Kan; Jian-rong Xu; Jiong Li; Yan-Jun Wen; Xing-chen Peng; Xiang Chen; Fei Yan; Bin Ye; Xiao-bo Du; Ju-mei Zhao; Tao Yi; Xian-cheng Chen; Xiao-xia Du; Yu-quan Wei; Xia Zhao
Journal:  Med Oncol       Date:  2009-12-01       Impact factor: 3.064

6.  Increased survivin expression confers chemoresistance to tumor-associated endothelial cells.

Authors:  Jenilyn J Virrey; Shengxi Guan; Wei Li; Axel H Schönthal; Thomas C Chen; Florence M Hofman
Journal:  Am J Pathol       Date:  2008-07-03       Impact factor: 4.307

Review 7.  Survivin: potential role in diagnosis, prognosis and targeted therapy of gastric cancer.

Authors:  Ting-Ting Wang; Xiao-Ping Qian; Bao-Rui Liu
Journal:  World J Gastroenterol       Date:  2007-05-28       Impact factor: 5.742

8.  Survivin and XIAP expression in distinct tumor compartments of surgically resected gastric cancer: XIAP as a prognostic marker in diffuse and mixed type adenocarcinomas.

Authors:  Levent Dizdar; Monika Tomczak; Thomas A Werner; Sami A Safi; Jasmin C Riemer; Pablo E Verde; Nikolas H Stoecklein; Wolfram T Knoefel; Andreas Krieg
Journal:  Oncol Lett       Date:  2017-09-19       Impact factor: 2.967

9.  Elevated survivin expression in peripheral blood mononuclear cells is central to collateral formation in coronary chronic total occlusion.

Authors:  Yiguan Xu; Xuerui Tan; Dongming Wang; Wei Wang; Yuguang Li; Min Wu; Songming Chen; Yinge Wu; Chunjiang Tan
Journal:  Int J Mol Med       Date:  2015-03-24       Impact factor: 4.101

Review 10.  Prognostic value of survivin in patients with gastric cancer: a systematic review with meta-analysis.

Authors:  Jin Long Liu; Wei Gao; Qing Min Kang; Xue Jun Zhang; Shu Guang Yang
Journal:  PLoS One       Date:  2013-08-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.